Sign Up Today and Learn More About Glooko Stock
Invest in or calculate the value of your shares in Glooko or other pre-IPO companies through EquityZen's platform.
About Glooko Stock
Founded
2010
Headquarters
Mountain View, CA, US
Total Funding
71.0M
Industries
Software, Health Care, Mobile
Glooko is the universal diabetes platform that provides insights to improve outcomes for people with diabetes (PWDs) and their care teams. Glooko connects to the world’s most popular diabetes devices, major fitness and activity trackers and supplies personalized, timely patient information such as glucose level, food, insulin, medications, blood pressure, diet and weight data. Trusted by the world’s leaders in diabetes care, we are in over 7,000 clinical locations and used by over 1.5 million PWDs in 23 countries across 15 languages. Learn more by visiting www.glooko.com.
Glooko Press Mentions
Stay in the know about the latest news on Glooko
Glooko Announces Presidents of Life Sciences and Connected Care
prnewswire • May 21, 2024
Better Therapeutics CEO talks partnership with Glooko
vator • Jan 13, 2024
Better Therapeutics and Glooko team to to integrate AspyreRx to treat T2D
thefly • Jan 05, 2024
Better Therapeutics adds digital treatment into Glooko’s diabetes management platform
fiercebiotech • Jan 04, 2024
Glooko Appoints Enrique Conterno, former Eli Lilly & Company Senior Executive, to Board of Directors
prnewswire • Oct 25, 2023
Investors in Glooko
Discover investors in Glooko stock and explore their portfolio companies
Glooko Management
Leadership team at Glooko
Chief Executive Officer
Russ Johannesson
Co-Founder
Yogen Dalal
Join now and verify your accreditation status to gain access to:
- Glooko current valuation
- Glooko stock price
- Available deals in Glooko and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Glooko stock?
Accredited investors can buy pre-IPO stock in companies like Glooko through EquityZen funds. These investments are made available by existing Glooko shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Glooko stock?
Shareholders can sell their Glooko stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
